Trump Administration’s CDC Cuts Threaten Safety and Progress in Blood Disorders“The Trump administration’s recent budget cuts to various health agencies under the US Department of Health and Human Services (HHS) could pose significant risks to patient safety and...
Incarcerated men sue Essex County sheriff for denying hepatitis C treatment“A federal class action lawsuit filed this week claims a controversial medical services contractor for Essex County jails — and by extension Sheriff Kevin Coppinger — refuses to provide...
FDA Greenlights Potent Nivolumab/Ipilimumab Combo for First-Line Use“The FDA granted approval for the combination of nivolumab (Opdivo) plus ipilimumab (Yervoy) as a first-line treatment for adults with unresectable hepatocellular carcinoma (HCC). This decision is...
CHLPI Tracks Impact of Innovative State Reentry Waivers on Hep C and HIV“Cambridge, MA – 3/12/2025 – The Center for Health Law and Policy Innovation (CHLPI) of Harvard Law School recently released an updated Reentry Waiver Tracker to highlight uptake and...
Protecting Key Populations From Abrupt Disruptions to Essential HIV Services“Prevention, testing and treatment services for HIV, viral hepatitis and sexually transmitted infections (STI) have driven unprecedented progress in improving population health over the past...
Community Surveys Show Enthusiasm for Long-Acting Hepatitis C Cure Research“People living with or at risk of hepatitis C virus (HCV), health care providers, and policymakers in low- and middle-income countries (LMICs) showed significant interest in a potential...
More News and Updates